IL6 and neoplasm: Subsequently, functional studies revealed that autocrine production of IL-6 by tumor cells confers resistance to several chemotherapeutic agents, suggesting that acquisition of the ability of tumor cells to produce IL-6 represents another self-protective mechanism (Conze et al., 2001).